Strong Network of Physicians & Clinical Sites
We are proud to collaborate with many of the leading cancer centers and physicians in the country. Our extensive clinical research network enables us to leverage several key benefits of investigator-initiated trials (IITs) to complement our company-sponsored trials. IITs enable us to be as close to addressing the true unmet need of patients as possible, are ideal for advancing early signal-finding for our programs, and remain rich in data generation and the exploration of fundamental biology questions.
Best-in-Class Early Development Network
Our focus and expertise as an organization lies in early-stage development through clinical proof-of-concept, and we have built an external network to support the execution of this work.
Activating this network appropriately as we move a program through the early stages of development enables us to apply a deep level of rigor to de-risking programs, working diligently to deliver focused data that supports whether a program or direction shows promise to address the target unmet need.
We support learning as much as we can in our clinical trials and through our far-reaching collaborations so that we can translate those insights to help current and future patients and drugs. As part of our commitment to bringing hope for life to patients, we invest in advancing the field through deep interrogation of patient biomarkers and secondary readouts in addition to advancing our own investigational medicines.